Literature DB >> 24760128

Developmental and pathological angiogenesis in the central nervous system.

Mario Vallon1, Junlei Chang, Haijing Zhang, Calvin J Kuo.   

Abstract

Angiogenesis, the formation of new blood vessels from pre-existing vessels, in the central nervous system (CNS) is seen both as a normal physiological response as well as a pathological step in disease progression. Formation of the blood-brain barrier (BBB) is an essential step in physiological CNS angiogenesis. The BBB is regulated by a neurovascular unit (NVU) consisting of endothelial and perivascular cells as well as vascular astrocytes. The NVU plays a critical role in preventing entry of neurotoxic substances and regulation of blood flow in the CNS. In recent years, research on numerous acquired and hereditary disorders of the CNS has increasingly emphasized the role of angiogenesis in disease pathophysiology. Here, we discuss molecular mechanisms of CNS angiogenesis during embryogenesis as well as various pathological states including brain tumor formation, ischemic stroke, arteriovenous malformations, and neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760128      PMCID: PMC4165859          DOI: 10.1007/s00018-014-1625-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  218 in total

Review 1.  Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.

Authors:  Mohammad S Alavijeh; Mansoor Chishty; M Zeeshan Qaiser; Alan M Palmer
Journal:  NeuroRx       Date:  2005-10

Review 2.  Making sense of latent TGFbeta activation.

Authors:  Justin P Annes; John S Munger; Daniel B Rifkin
Journal:  J Cell Sci       Date:  2003-01-15       Impact factor: 5.285

3.  Anti-angiogenesis: new concept for therapy of solid tumors.

Authors:  J Folkman
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

4.  Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling.

Authors:  Heike Beck; Till Acker; Andreas W Püschel; Hajime Fujisawa; Peter Carmeliet; Karl H Plate
Journal:  J Neuropathol Exp Neurol       Date:  2002-04       Impact factor: 3.685

5.  Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.

Authors:  James J Vredenburgh; Annick Desjardins; James E Herndon; Jeannette M Dowell; David A Reardon; Jennifer A Quinn; Jeremy N Rich; Sith Sathornsumetee; Sridharan Gururangan; Melissa Wagner; Darell D Bigner; Allan H Friedman; Henry S Friedman
Journal:  Clin Cancer Res       Date:  2007-02-15       Impact factor: 12.531

6.  The neural tube patterns vessels developmentally using the VEGF signaling pathway.

Authors:  Kelly A Hogan; Carrie A Ambler; Deborah L Chapman; Victoria L Bautch
Journal:  Development       Date:  2004-03-03       Impact factor: 6.868

7.  A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q.

Authors:  P Vincent; H Plauchu; J Hazan; S Fauré; J Weissenbach; J Godet
Journal:  Hum Mol Genet       Date:  1995-05       Impact factor: 6.150

8.  Expression and localization of claudins-3 and -12 in transformed human brain endothelium.

Authors:  Anja Schrade; Hadassah Sade; Pierre-Olivier Couraud; Ignacio A Romero; Babette B Weksler; Jens Niewoehner
Journal:  Fluids Barriers CNS       Date:  2012-02-29

Review 9.  Inflammatory mechanisms in ischemic stroke: therapeutic approaches.

Authors:  Shaheen E Lakhan; Annette Kirchgessner; Magdalena Hofer
Journal:  J Transl Med       Date:  2009-11-17       Impact factor: 5.531

10.  Wnt/beta-catenin signaling controls development of the blood-brain barrier.

Authors:  Stefan Liebner; Monica Corada; Thorsten Bangsow; Jane Babbage; Andrea Taddei; Cathrin J Czupalla; Marco Reis; Angelina Felici; Hartwig Wolburg; Marcus Fruttiger; Makoto M Taketo; Harald von Melchner; Karl Heinz Plate; Holger Gerhardt; Elisabetta Dejana
Journal:  J Cell Biol       Date:  2008-10-27       Impact factor: 10.539

View more
  35 in total

1.  Reck enables cerebrovascular development by promoting canonical Wnt signaling.

Authors:  Florian Ulrich; Jorge Carretero-Ortega; Javier Menéndez; Carlos Narvaez; Belinda Sun; Eva Lancaster; Valerie Pershad; Sean Trzaska; Evelyn Véliz; Makoto Kamei; Andrew Prendergast; Kameha R Kidd; Kenna M Shaw; Daniel A Castranova; Van N Pham; Brigid D Lo; Benjamin L Martin; David W Raible; Brant M Weinstein; Jesús Torres-Vázquez
Journal:  Development       Date:  2015-12-10       Impact factor: 6.868

2.  Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.

Authors:  Timothy N Phoenix; Deanna M Patmore; Scott Boop; Nidal Boulos; Megan O Jacus; Yogesh T Patel; Martine F Roussel; David Finkelstein; Liliana Goumnerova; Sebastien Perreault; Elizabeth Wadhwa; Yoon-Jae Cho; Clinton F Stewart; Richard J Gilbertson
Journal:  Cancer Cell       Date:  2016-03-31       Impact factor: 31.743

Review 3.  Applications and development of permeability imaging in ischemic stroke.

Authors:  Hui Chen; Guangming Zhu; Nan Liu; Ying Li; Yonghong Xia
Journal:  Exp Ther Med       Date:  2018-07-17       Impact factor: 2.447

4.  Functional effects of blocking VEGF/VEGFR2 signaling in the rat urinary bladder in acute and chronic CYP-induced cystitis.

Authors:  Katharine Tooke; Beatrice Girard; Margaret A Vizzard
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-17

5.  Cerebrovascular defects in Foxc1 mutants correlate with aberrant WNT and VEGF-A pathways downstream of retinoic acid from the meninges.

Authors:  Swati Mishra; Youngshik Choe; Samuel J Pleasure; Julie A Siegenthaler
Journal:  Dev Biol       Date:  2016-09-23       Impact factor: 3.582

Review 6.  Cerebral insulin, insulin signaling pathway, and brain angiogenesis.

Authors:  Yi Zeng; Le Zhang; Zhiping Hu
Journal:  Neurol Sci       Date:  2015-10-06       Impact factor: 3.307

7.  Connexin43 promotes angiogenesis through activating the HIF-1α/VEGF signaling pathway under chronic cerebral hypoperfusion.

Authors:  Weiwei Yu; Haiqiang Jin; Wei Sun; Ding Nan; Jianwen Deng; Jingjing Jia; Zemou Yu; Yining Huang
Journal:  J Cereb Blood Flow Metab       Date:  2021-04-25       Impact factor: 6.200

8.  Activation of astroglial CB1R mediates cerebral ischemic tolerance induced by electroacupuncture.

Authors:  Cen Yang; Jingjing Liu; Jingyi Wang; Anqi Yin; Zhenhua Jiang; Shuwei Ye; Xue Liu; Xia Zhang; Feng Wang; Lize Xiong
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-04       Impact factor: 6.200

9.  Gpr124 is essential for blood-brain barrier integrity in central nervous system disease.

Authors:  Junlei Chang; Michael R Mancuso; Carolina Maier; Xibin Liang; Kanako Yuki; Lu Yang; Jeffrey W Kwong; Jing Wang; Varsha Rao; Mario Vallon; Cynthia Kosinski; J J Haijing Zhang; Amanda T Mah; Lijun Xu; Le Li; Sharareh Gholamin; Teresa F Reyes; Rui Li; Frank Kuhnert; Xiaoyuan Han; Jenny Yuan; Shin-Heng Chiou; Ari D Brettman; Lauren Daly; David C Corney; Samuel H Cheshier; Linda D Shortliffe; Xiwei Wu; Michael Snyder; Pak Chan; Rona G Giffard; Howard Y Chang; Katrin Andreasson; Calvin J Kuo
Journal:  Nat Med       Date:  2017-03-13       Impact factor: 87.241

10.  Tissue factor pathway inhibitor is required for cerebrovascular development in mice.

Authors:  Susan A Maroney; Randal J Westrick; Audrey C Cleuren; Nicholas D Martinez; Amy E Siebert; Mark Zogg; David Ginsburg; Hartmut Weiler; Alan E Mast
Journal:  Blood       Date:  2021-01-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.